Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis-Reference-Cited by-同舟云学术

Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis

Published:2024-04 Issue:4 Volume:14 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Malhotra Sunny¹,Fissolo Nicolas¹,Rodríguez‐Rivera Carmen²,Monreal Enric³,Montpeyo Marta⁴^ORCID,Urcelay Elena⁵^ORCID,Triviño Juan Carlos⁶,Pérez‐García María José⁷,Segura Miguel F.⁷^ORCID,Pappolla Agustín¹,Río Jordi¹,Vilaseca Andreu¹,Fernández Velasco José Ignacio³,Miguez Andrés¹,Goicoechea Carlos²,Martinez‐Vicente Marta⁴,Villar Luisa M³,Montalban Xavier¹,Comabella Manuel¹^ORCID

Affiliation:

1. Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona Barcelona Spain

2. Area of Pharmacology and Nutrition & Bromatology Department of Basic Health Sciences Universidad Rey Juan Carlos, Alcorcón Madrid Spain

3. Department of Neurology Hospital Universitario Ramón y Cajal REEM IRYCIS Universidad de Alcalá Madrid Spain

4. Neurodegenerative Diseases Research Group, Institut de Recerca Vall d'Hebron (VHIR) ‐ Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) Barcelona Spain

5. Laboratorio de Investigación en Genética de Enfermedades Complejas Instituto de Investigación Sanitaria San Carlos (IdISSC) Madrid Spain

6. Genomic Systems Valencia Spain

7. Group of Childhood Cancer and Blood Disorders Institut de Recerca Vall d'He bron (VHIR) Universitat Autònoma de Barcelona Barcelona Spain

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1654

Reference10 articles.

1. Measures in the first year of therapy predict the response to interferon β in MS

2. An updated review of teriflunomide's use in multiple sclerosis

3. Clusterin levels in undernourished SH‐SY5Y cells;Rodríguez‐Rivera C;Food Nutr Res,2021

4. Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cells

5. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects